nodes	percent_of_prediction	percent_of_DWPC	metapath
Anisotropine Methylbromide—Valproic Acid—HDAC9—hematologic cancer	0.101	0.608	CrCbGaD
Anisotropine Methylbromide—Valproic Acid—HDAC2—hematologic cancer	0.0648	0.392	CrCbGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—PDGFA—hematologic cancer	0.000203	0.000243	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—MAP2K1—hematologic cancer	0.000202	0.000243	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—GRB2—hematologic cancer	0.000201	0.000241	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—PIK3CD—hematologic cancer	0.000201	0.000241	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—PDGFA—hematologic cancer	0.000201	0.000241	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—KITLG—hematologic cancer	0.000201	0.00024	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—KITLG—hematologic cancer	0.0002	0.00024	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—KITLG—hematologic cancer	0.000198	0.000237	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—STAT5A—hematologic cancer	0.000196	0.000235	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR downstream signaling—PIK3CB—hematologic cancer	0.000196	0.000234	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—STAT5A—hematologic cancer	0.000196	0.000234	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR downstream signaling—PIK3CB—hematologic cancer	0.000195	0.000234	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—CDKN2B—hematologic cancer	0.000194	0.000233	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—MTHFR—hematologic cancer	0.000194	0.000233	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—CDKN2B—hematologic cancer	0.000194	0.000232	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—STAT5A—hematologic cancer	0.000194	0.000232	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR downstream signaling—PIK3CB—hematologic cancer	0.000193	0.000231	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—PIK3R1—hematologic cancer	0.000192	0.00023	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—CDKN2B—hematologic cancer	0.000192	0.00023	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—PIK3R1—hematologic cancer	0.000192	0.00023	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—PIK3R1—hematologic cancer	0.00019	0.000228	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—CD86—hematologic cancer	0.000188	0.000225	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—CD86—hematologic cancer	0.000187	0.000225	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—JAK2—hematologic cancer	0.000187	0.000224	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—JAK2—hematologic cancer	0.000186	0.000223	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—CD86—hematologic cancer	0.000186	0.000222	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—HES1—hematologic cancer	0.000185	0.000222	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—HES1—hematologic cancer	0.000185	0.000221	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—JAK2—hematologic cancer	0.000185	0.000221	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—NCOR1—hematologic cancer	0.000184	0.000221	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—NCOR1—hematologic cancer	0.000184	0.00022	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—HES1—hematologic cancer	0.000183	0.000219	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—FGF1—hematologic cancer	0.000182	0.000218	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—CSF2—hematologic cancer	0.000182	0.000218	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—NCOR1—hematologic cancer	0.000182	0.000218	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—CSF2—hematologic cancer	0.000182	0.000218	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—FGF1—hematologic cancer	0.000182	0.000218	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—CSF2—hematologic cancer	0.00018	0.000216	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—FGF1—hematologic cancer	0.00018	0.000216	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—FOXO1—hematologic cancer	0.00018	0.000215	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR downstream signaling—IL2—hematologic cancer	0.00018	0.000215	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—PDGFRB—hematologic cancer	0.000179	0.000215	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—FOXO1—hematologic cancer	0.000179	0.000215	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR downstream signaling—IL2—hematologic cancer	0.000179	0.000214	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—PDGFRB—hematologic cancer	0.000179	0.000214	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—PIK3CB—hematologic cancer	0.000178	0.000213	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—FOXO1—hematologic cancer	0.000177	0.000213	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR downstream signaling—IL2—hematologic cancer	0.000177	0.000212	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—PDGFRB—hematologic cancer	0.000177	0.000212	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—PIK3CB—hematologic cancer	0.000177	0.000212	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—PDGFRA—hematologic cancer	0.000177	0.000212	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—PDGFRA—hematologic cancer	0.000176	0.000211	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—JAK1—hematologic cancer	0.000176	0.000211	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—PRKCG—hematologic cancer	0.000176	0.000211	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—JAK1—hematologic cancer	0.000175	0.00021	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—PRKCG—hematologic cancer	0.000175	0.00021	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—PIK3CB—hematologic cancer	0.000175	0.00021	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—PDGFRA—hematologic cancer	0.000174	0.000209	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—JAK1—hematologic cancer	0.000174	0.000208	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—PRKCG—hematologic cancer	0.000174	0.000208	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—IL2RA—hematologic cancer	0.000164	0.000197	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—IL2RA—hematologic cancer	0.000164	0.000196	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—PIK3CG—hematologic cancer	0.000163	0.000196	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—IL2—hematologic cancer	0.000163	0.000195	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—IL2—hematologic cancer	0.000163	0.000195	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—TERT—hematologic cancer	0.000163	0.000195	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—IL2RA—hematologic cancer	0.000162	0.000194	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—TERT—hematologic cancer	0.000162	0.000194	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—IL2—hematologic cancer	0.000161	0.000193	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—TERT—hematologic cancer	0.00016	0.000192	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—PDGFB—hematologic cancer	0.000159	0.00019	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—PDGFB—hematologic cancer	0.000158	0.000189	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—PDGFB—hematologic cancer	0.000157	0.000188	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—TSC2—hematologic cancer	0.000155	0.000186	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—TSC2—hematologic cancer	0.000155	0.000185	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—TSC2—hematologic cancer	0.000153	0.000183	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—CREBBP—hematologic cancer	0.000151	0.000181	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—FGFR3—hematologic cancer	0.000149	0.000179	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—FGFR3—hematologic cancer	0.000149	0.000178	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—MAPK14—hematologic cancer	0.000148	0.000177	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—FGFR3—hematologic cancer	0.000147	0.000176	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—MAPK14—hematologic cancer	0.000147	0.000176	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—MAPK14—hematologic cancer	0.000146	0.000175	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—ESR1—hematologic cancer	0.000145	0.000174	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—ESR1—hematologic cancer	0.000144	0.000173	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—PIK3CD—hematologic cancer	0.000143	0.000172	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—FN1—hematologic cancer	0.000143	0.000171	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—ESR1—hematologic cancer	0.000143	0.000171	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—FN1—hematologic cancer	0.000143	0.000171	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—ALB—hematologic cancer	0.000142	0.00017	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—BAD—hematologic cancer	0.000141	0.000169	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—NFKBIA—hematologic cancer	0.000141	0.000169	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—FN1—hematologic cancer	0.000141	0.000169	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—BAD—hematologic cancer	0.000141	0.000169	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—NFKBIA—hematologic cancer	0.000141	0.000169	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—NOTCH1—hematologic cancer	0.00014	0.000168	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—NOTCH1—hematologic cancer	0.00014	0.000167	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—BAD—hematologic cancer	0.00014	0.000167	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—NFKBIA—hematologic cancer	0.00014	0.000167	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—NOTCH1—hematologic cancer	0.000138	0.000166	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—CD80—hematologic cancer	0.000137	0.000164	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—KIT—hematologic cancer	0.000137	0.000164	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—PIK3CG—hematologic cancer	0.000137	0.000164	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—NRAS—hematologic cancer	0.000137	0.000164	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—CD80—hematologic cancer	0.000137	0.000164	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—PIK3CG—hematologic cancer	0.000136	0.000164	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—KIT—hematologic cancer	0.000136	0.000164	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—NRAS—hematologic cancer	0.000136	0.000164	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—PIK3R1—hematologic cancer	0.000136	0.000162	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—CD80—hematologic cancer	0.000135	0.000162	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—PIK3CG—hematologic cancer	0.000135	0.000162	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—KIT—hematologic cancer	0.000135	0.000162	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—NRAS—hematologic cancer	0.000135	0.000162	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—PTPN11—hematologic cancer	0.000135	0.000161	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—PTPN11—hematologic cancer	0.000134	0.000161	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—PTPN11—hematologic cancer	0.000133	0.000159	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—MAPK3—hematologic cancer	0.000131	0.000157	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—MAPK3—hematologic cancer	0.000131	0.000157	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—CREB1—hematologic cancer	0.00013	0.000156	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—CREB1—hematologic cancer	0.00013	0.000156	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—MAPK3—hematologic cancer	0.000129	0.000155	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—BRAF—hematologic cancer	0.000129	0.000154	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—CREB1—hematologic cancer	0.000129	0.000154	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—BRAF—hematologic cancer	0.000128	0.000154	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—CCL2—hematologic cancer	0.000128	0.000153	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—IL6R—hematologic cancer	0.000127	0.000152	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—CCL2—hematologic cancer	0.000127	0.000152	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—BRAF—hematologic cancer	0.000127	0.000152	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—CREBBP—hematologic cancer	0.000127	0.000152	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—IL6R—hematologic cancer	0.000127	0.000152	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—CREBBP—hematologic cancer	0.000127	0.000152	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—CCL2—hematologic cancer	0.000126	0.000151	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—IL6R—hematologic cancer	0.000126	0.00015	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—CREBBP—hematologic cancer	0.000125	0.00015	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—PIK3CB—hematologic cancer	0.000125	0.00015	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—MAP2K1—hematologic cancer	0.000121	0.000145	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—MAP2K1—hematologic cancer	0.000121	0.000145	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—PIK3CD—hematologic cancer	0.00012	0.000144	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—PIK3CD—hematologic cancer	0.00012	0.000144	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—MAP2K1—hematologic cancer	0.00012	0.000143	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR downstream signaling—PIK3CA—hematologic cancer	0.000119	0.000143	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR downstream signaling—PIK3CA—hematologic cancer	0.000119	0.000142	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—PIK3CD—hematologic cancer	0.000119	0.000142	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—KRAS—hematologic cancer	0.000118	0.000141	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR downstream signaling—PIK3CA—hematologic cancer	0.000118	0.000141	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—KRAS—hematologic cancer	0.000117	0.000141	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—KRAS—hematologic cancer	0.000116	0.000139	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—FGF2—hematologic cancer	0.000115	0.000138	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—FGF2—hematologic cancer	0.000115	0.000138	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—FGF2—hematologic cancer	0.000114	0.000136	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—PIK3R1—hematologic cancer	0.000114	0.000136	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—PIK3R1—hematologic cancer	0.000113	0.000136	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—PIK3R1—hematologic cancer	0.000112	0.000134	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—JAK2—hematologic cancer	0.00011	0.000132	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—JAK2—hematologic cancer	0.00011	0.000132	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—JAK2—hematologic cancer	0.000109	0.000131	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—PIK3CA—hematologic cancer	0.000108	0.00013	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—PTEN—hematologic cancer	0.000108	0.000129	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—PIK3CA—hematologic cancer	0.000108	0.000129	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—MDM2—hematologic cancer	0.000108	0.000129	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—MDM2—hematologic cancer	0.000107	0.000129	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—PIK3CA—hematologic cancer	0.000107	0.000128	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—MDM2—hematologic cancer	0.000106	0.000128	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—MTOR—hematologic cancer	0.000105	0.000126	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—PIK3CB—hematologic cancer	0.000105	0.000126	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—MTOR—hematologic cancer	0.000105	0.000125	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—PIK3CB—hematologic cancer	0.000105	0.000125	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—PIK3CB—hematologic cancer	0.000104	0.000124	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—MTOR—hematologic cancer	0.000104	0.000124	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—EP300—hematologic cancer	0.000103	0.000123	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—HRAS—hematologic cancer	0.0001	0.00012	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—HRAS—hematologic cancer	9.99e-05	0.00012	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—HRAS—hematologic cancer	9.89e-05	0.000118	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—CDKN1B—hematologic cancer	9.85e-05	0.000118	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—CDKN1B—hematologic cancer	9.81e-05	0.000118	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR downstream signaling—AKT1—hematologic cancer	9.74e-05	0.000117	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—CDKN1B—hematologic cancer	9.72e-05	0.000116	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR downstream signaling—AKT1—hematologic cancer	9.71e-05	0.000116	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—CASP3—hematologic cancer	9.65e-05	0.000116	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—IL2—hematologic cancer	9.64e-05	0.000115	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—CASP3—hematologic cancer	9.62e-05	0.000115	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR downstream signaling—AKT1—hematologic cancer	9.61e-05	0.000115	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—IL2—hematologic cancer	9.6e-05	0.000115	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—IL6—hematologic cancer	9.59e-05	0.000115	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—IL6—hematologic cancer	9.56e-05	0.000114	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—CASP3—hematologic cancer	9.53e-05	0.000114	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—IL2—hematologic cancer	9.51e-05	0.000114	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—IL6—hematologic cancer	9.46e-05	0.000113	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—CCND1—hematologic cancer	9.39e-05	0.000113	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—JUN—hematologic cancer	9.37e-05	0.000112	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—CCND1—hematologic cancer	9.36e-05	0.000112	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—JUN—hematologic cancer	9.34e-05	0.000112	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—CCND1—hematologic cancer	9.27e-05	0.000111	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—JUN—hematologic cancer	9.25e-05	0.000111	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—CDKN1A—hematologic cancer	9.09e-05	0.000109	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—PTEN—hematologic cancer	9.07e-05	0.000109	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—CDKN1A—hematologic cancer	9.06e-05	0.000109	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—PTEN—hematologic cancer	9.04e-05	0.000108	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—CDKN1A—hematologic cancer	8.97e-05	0.000107	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—PTEN—hematologic cancer	8.95e-05	0.000107	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—MAPK8—hematologic cancer	8.87e-05	0.000106	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—AKT1—hematologic cancer	8.84e-05	0.000106	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—MAPK8—hematologic cancer	8.84e-05	0.000106	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—AKT1—hematologic cancer	8.82e-05	0.000106	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—MAPK8—hematologic cancer	8.76e-05	0.000105	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—AKT1—hematologic cancer	8.73e-05	0.000105	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—EP300—hematologic cancer	8.65e-05	0.000104	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—EP300—hematologic cancer	8.62e-05	0.000103	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—EP300—hematologic cancer	8.54e-05	0.000102	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—SRC—hematologic cancer	8.41e-05	0.000101	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—SRC—hematologic cancer	8.38e-05	0.0001	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—SRC—hematologic cancer	8.3e-05	9.94e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—VEGFA—hematologic cancer	8.19e-05	9.81e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—VEGFA—hematologic cancer	8.16e-05	9.78e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—STAT3—hematologic cancer	8.11e-05	9.71e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—NRAS—hematologic cancer	8.09e-05	9.69e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—VEGFA—hematologic cancer	8.08e-05	9.68e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—STAT3—hematologic cancer	8.08e-05	9.68e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—NRAS—hematologic cancer	8.06e-05	9.66e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—STAT3—hematologic cancer	8e-05	9.59e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—NRAS—hematologic cancer	7.98e-05	9.56e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—MAPK3—hematologic cancer	7.75e-05	9.28e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—MAPK3—hematologic cancer	7.72e-05	9.25e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—MAPK3—hematologic cancer	7.65e-05	9.16e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—PIK3CA—hematologic cancer	7.62e-05	9.13e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—MYC—hematologic cancer	7.53e-05	9.03e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—TGFB1—hematologic cancer	7.52e-05	9e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—MYC—hematologic cancer	7.51e-05	9e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—TGFB1—hematologic cancer	7.49e-05	8.98e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—MYC—hematologic cancer	7.44e-05	8.91e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—TGFB1—hematologic cancer	7.42e-05	8.89e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—KRAS—hematologic cancer	6.96e-05	8.34e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—KRAS—hematologic cancer	6.94e-05	8.31e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—KRAS—hematologic cancer	6.87e-05	8.23e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—PIK3CA—hematologic cancer	6.4e-05	7.66e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—PIK3CA—hematologic cancer	6.38e-05	7.64e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—PIK3CA—hematologic cancer	6.31e-05	7.56e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—AKT1—hematologic cancer	6.23e-05	7.46e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—TP53—hematologic cancer	6.19e-05	7.41e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—TP53—hematologic cancer	6.17e-05	7.39e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—TP53—hematologic cancer	6.11e-05	7.32e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—HRAS—hematologic cancer	5.92e-05	7.09e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—HRAS—hematologic cancer	5.9e-05	7.07e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—HRAS—hematologic cancer	5.84e-05	7e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—IL6—hematologic cancer	5.66e-05	6.78e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—IL6—hematologic cancer	5.65e-05	6.76e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—IL6—hematologic cancer	5.59e-05	6.7e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—AKT1—hematologic cancer	5.22e-05	6.26e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—AKT1—hematologic cancer	5.21e-05	6.24e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—AKT1—hematologic cancer	5.16e-05	6.18e-05	CbGpPWpGaD
